Literature DB >> 8807330

Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core.

F J Couch1, B L Weber.   

Abstract

Mutations in the familial early-onset breast cancer gene (BRCA1) account for approximately 2-5% of all breast cancer cases (Easton et al., 1993). Since the isolation of the BRCA1 gene in 1994, many mutations have been identified. We report here a total of 254 BRCA1 mutations, 132 (52%) of which are unique. These represent mutations entered into a database established by the Breast Cancer Information Core (BIC), which have appeared in the literature or have been submitted by BIC members and other contributors prior to publication. A total of 221 (87%) of all mutations or 107 (81%) of the unique mutations are small deletions, insertions, nonsense point mutations, splice variants, and regulatory mutations that result in truncation or absence of the BRCA1 protein. A total of 11 disease-associated missense mutations (5 unique), and 21 variants (19 unique) as yet unclassified as either missense mutations or polymorphisms have been detected. Thirty-five independent benign polymorphisms are also described. The most common mutations are 185delAG and 5382insC, which account for 30 (11.7%) and 26 (10.1%), respectively, of all mutations shown. The biological and clinical relevance of these BRCA1 mutations is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807330     DOI: 10.1002/humu.1380080102

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  64 in total

1.  PTIP, a novel BRCT domain-containing protein interacts with Pax2 and is associated with active chromatin.

Authors:  M S Lechner; I Levitan; G R Dressler
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

2.  Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains.

Authors:  Donna L Mallery; Cassandra J Vandenberg; Kevin Hiom
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

3.  Personalized genomic analyses for cancer mutation discovery and interpretation.

Authors:  Siân Jones; Valsamo Anagnostou; Karli Lytle; Sonya Parpart-Li; Monica Nesselbush; David R Riley; Manish Shukla; Bryan Chesnick; Maura Kadan; Eniko Papp; Kevin G Galens; Derek Murphy; Theresa Zhang; Lisa Kann; Mark Sausen; Samuel V Angiuoli; Luis A Diaz; Victor E Velculescu
Journal:  Sci Transl Med       Date:  2015-04-15       Impact factor: 17.956

Review 4.  [Evaluation of cancer risk through genetic analysis?].

Authors:  A Luz
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

5.  The dependence of the risk of breast cancer in women on their genotype.

Authors:  V A Tarasov; M M Aslanyan; E S Tsyrendorzhieva; R F Gar'kavtseva; L N Lyubchenko; Yu P Altukhov
Journal:  Dokl Biol Sci       Date:  2004 Sep-Oct

Review 6.  Functional assays for BRCA1 and BRCA2.

Authors:  Marcelo A Carvalho; Fergus J Couch; Alvaro N A Monteiro
Journal:  Int J Biochem Cell Biol       Date:  2006-08-18       Impact factor: 5.085

7.  SCWRL and MolIDE: computer programs for side-chain conformation prediction and homology modeling.

Authors:  Qiang Wang; Adrian A Canutescu; Roland L Dunbrack
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

8.  'A variant of uncertain significance' and the proliferation of human disease gene databases.

Authors:  David R Nelson
Journal:  Hum Genomics       Date:  2005-03       Impact factor: 4.639

9.  Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability.

Authors:  Ellen E McCarthy; Julide T Celebi; Richard Baer; Thomas Ludwig
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

10.  Locus-specific databases and recommendations to strengthen their contribution to the classification of variants in cancer susceptibility genes.

Authors:  Marc S Greenblatt; Lawrence C Brody; William D Foulkes; Maurizio Genuardi; Robert M W Hofstra; Magali Olivier; Sharon E Plon; Rolf H Sijmons; Olga Sinilnikova; Amanda B Spurdle
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.